biote Corp.

BTMD Healthcare Medical Care Facilities

biote Corp.’s revenue for fiscal 2025 (year ended December 2025) was $192.2 million, down 2.52% from fiscal 2024.

Revenue
−9.48%
EPS
−330.0%
Free cash flow
−174.2%
Total debt
+16.0%

Quarter to June 2026, against a year earlier

1.06 0.02 +1.92%
Market cap
$37.4M
P/E
6.6×
Fwd P/E
−5.4×
Dividend yield
—
F-score
7/9
Altman Z
2.65
Beneish M
−2.72
Dividend safety
n/a

biote Corp. (BTMD) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, biote Corp. (BTMD) trades at a P/E ratio of 6.6×. Over the past ten years it has ranged from 0.0× (March 2024) to 70.4× (June 2024); the current reading is higher than 72% of that period. That is below the Medical Care Facilities industry median of 18.7× and below the Healthcare sector median of 24.5×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 3.0× (92.66%)
FY2024 41.2× —
FY2023 0.0× —
FY2022 0.3× —
FY2021 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 11.8× 328.75%
Mar 2026 2.8× (8.87%)
Dec 2025 3.0× (7.29%)
Sep 2025 3.3× (18.88%)
17 more quarters

Against its own ten years

Low 0.0× High 70.4×
Ten-year median 2.6×
Current reading's percentile 63

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on BTMD